Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

NCT07123493 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Strategic Portfolio Decision

Conditions

Recurrent or Metastatic Solid Tumors With Positive ALPP

Interventions

BIOLOGICAL: Anti ALPP CAR-T cells treatment

Sponsor

Haifeng Qin